ATC code L04

L04AA Selective immunosuppressants

 * L04AA03 Antilymphocyte immunoglobulin (horse)
 * L04AA04 Antithymocyte immunoglobulin (rabbit)
 * L04AA06 Mycophenolic acid
 * L04AA15 Alefacept
 * L04AA19 Gusperimus
 * L04AA22 Abetimus
 * L04AA24 Abatacept
 * L04AA28 Belatacept
 * L04AA32 Apremilast
 * L04AA40 Cladribine
 * L04AA41 Imlifidase
 * L04AA48 Belumosudil
 * L04AA58 Efgartigimod alfa

L04AB Tumor necrosis factor alpha (TNF-α) inhibitors

 * L04AB01 Etanercept
 * L04AB02 Infliximab
 * L04AB03 Afelimomab
 * L04AB04 Adalimumab
 * L04AB05 Certolizumab pegol
 * L04AB06 Golimumab
 * L04AB07 Opinercept

L04AC Interleukin inhibitors

 * L04AC01 Daclizumab
 * L04AC02 Basiliximab
 * L04AC03 Anakinra
 * L04AC04 Rilonacept
 * L04AC05 Ustekinumab
 * L04AC07 Tocilizumab
 * L04AC08 Canakinumab
 * L04AC09 Briakinumab
 * L04AC10 Secukinumab
 * L04AC11 Siltuximab
 * L04AC12 Brodalumab
 * L04AC13 Ixekizumab
 * L04AC14 Sarilumab
 * L04AC15 Sirukumab
 * L04AC16 Guselkumab
 * L04AC17 Tildrakizumab
 * L04AC18 Risankizumab
 * L04AC19 Satralizumab
 * L04AC20 Netakimab
 * L04AC21 Bimekizumab
 * L04AC22 Spesolimab
 * L04AC23 Olokizumab

L04AD Calcineurin inhibitors

 * L04AD01 Ciclosporin
 * L04AD02 Tacrolimus
 * L04AD03 Voclosporin

L04AE Sphingosine 1-phosphate (S1P) receptor modulators

 * L04AE01 Fingolimod
 * L04AE02 Ozanimod
 * L04AE03 Siponimod
 * L04AE04 Ponesimod
 * L04AE05 Etrasimod

L04AF Janus-associated kinase (JAK) inhibitors

 * L04AF01 Tofacitinib
 * L04AF02 Baricitinib
 * L04AF03 Upadacitinib
 * L04AF04 Filgotinib
 * L04AF05 Itacitinib
 * L04AF06 Peficitinib
 * L04AF07 Deucravacitinib
 * L04AF08 Ritlecitinib

L04AG Monoclonal antibodies

 * L04AG01 Muromonab-CD3
 * L04AG02 Efalizumab
 * L04AG03 Natalizumab
 * L04AG04 Belimumab
 * L04AG05 Vedolizumab
 * L04AG06 Alemtuzumab
 * L04AG07 Begelomab
 * L04AG08 Ocrelizumab
 * L04AG09 Emapalumab
 * L04AG10 Inebilizumab
 * L04AG11 Anifrolumab
 * L04AG12 Ofatumumab
 * L04AG13 Teprotumumab
 * L04AG14 Ublituximab
 * L04AG15 Divozilimab
 * L04AG16 Rozanolixizumab

L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors

 * L04AH01 Sirolimus
 * L04AH02 Everolimus

L04AJ Complement inhibitors

 * L04AJ01 Eculizumab
 * L04AJ02 Ravulizumab
 * L04AJ03 Pegcetacoplan
 * L04AJ04 Sutimlimab
 * L04AJ05 Avacopan
 * L04AJ06 Zilucoplan
 * L04AJ07 Crovalimab
 * L04AJ08 Iptacopan
 * L04AJ09 Danicopan

L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors

 * L04AK01 Leflunomide
 * L04AK02 Teriflunomide

L04AX Other immunosuppressants

 * L04AX01 Azathioprine
 * L04AX02 Thalidomide
 * L04AX03 Methotrexate
 * L04AX04 Lenalidomide
 * L04AX05 Pirfenidone
 * L04AX06 Pomalidomide
 * L04AX07 Dimethyl fumarate
 * L04AX08 Darvadstrocel
 * L04AX09 Diroximel fumarate